IP Library Granted Patent US 7,276,059
Granted Patent B2
US 7,276,059 · App. 10/799,337 · Granted Oct 2, 2007

Treatment of skin disorders with UV light and cooling

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,276,059
App. No.
10/799,337
Granted
Oct 2, 2007
Kind
B2
Abstract

Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED, as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas The skin can be cooled prior to and/or during exposure to UV light to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.

Claims (7)

1. A method for treating an epidermal region comprising diseased tissue, the method comprising:

cooling the diseased tissue to below about 0° C. and exposing the diseased tissue in said epidermal region to a dosage of ultraviolet light between about 16 and 20 minimum erythema doses (MED) in the wavelength range of between about 300 and 315 nanometers.

2. The method of claim 1 , wherein the epidermal region exposed to ultraviolet has an area between about 1 cm 2 and about 4 cm 2 .

3. The method of claim 1 , wherein cooling comprises spraying the skin with a cool liquid, gas, or air.

4. The method of claim 1 , wherein cooling comprise contacting the diseased tissue with a chilled surface.

5. The method of claim 1 , wherein the diseased tissue is cooled to below about −5° C.

6. The method of claim 1 , further comprising determining the MED of a patient having said epidermal tissue.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 20, 2020
From: MIDCAP FINANCIAL TRUST
To: STRATA SKIN SCIENCES, INC.
Reel/Frame 051558/0510 →
CHANGE OF NAME Recorded Oct 20, 2017
From: MELA SCIENCES, INC.
To: STRATA SKIN SCIENCES, INC.
Reel/Frame 044255/0358 →
SECURITY INTEREST Recorded Dec 31, 2015
From: MELA SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037391/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2015
From: PHOTOMEDEX TECHNOLOGY, INC.
To: MELA SCIENCES, INC.
Reel/Frame 036236/0243 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 3, 2015
From: PHOTOMEDEX, INC.
To: PHOTOMEDEX TECHNOLOGY, INC.
Reel/Frame 036236/0201 →
RELEASE OF SECURITY INTEREST Recorded Jun 23, 2015
From: JPMORGAN CHASE BANK, N.A.
To: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
Reel/Frame 036007/0222 →
SECURITY INTEREST Recorded May 14, 2014
From: PHOTOMEDEX, INC.; GATORADE ACQUISITION CORP.; RADIANCY, INC.; PHOTOMEDEX TECHNOLOGY, INC.; LUMIERE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032892/0586 →